BIONTECH SE SPONSORED ADR
(NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

103.560

-7.920 (-7.10%)
价格区间 102.140 - 115.930   (13.50%)
开盘 112.900
昨收 111.480
买 116.800
买盘 12
卖 116.990
卖盘 8
成交量 1,656,371
成交额 -
注释
数据延迟。最后一次更新15 Nov 2024 05:00.
数据提供商
查看所有活动

Loading Chart...

Please login to view stock data and analysis